Viruses versus Humans

03/06/2026

In this Viewpoint, Søren Paludan (Aarhus Universitet) and Sara Cherry (Perelman School of Medicine at the University of Pennsylvania) reflect on the recent outbreak and discuss the need for a better understanding of the different phases of viral diseases to improve treatment. https://hubs.la/Q04h_P_40

03/06/2026

Rasmussen Retorts #8: Why Ebola isn't going to "Go Airborne" 〰️ We have now reached the stage of the Bundibugyo ebolavirus outbreak where the “what if it goes airborne” discussion really starts to rev up. 📺 bit.ly/4x0H1t3

02/06/2026

"Bad experiences with supervisors are one of the leading reasons that early-career researchers leave . In a survey of more than 2,600 researchers, almost 40% of respondents said that their supervisor was disorganized and poor at communication and at least 30% reported issues concerning their supervisor’s behaviour, such as abrupt attitude changes and a lack of empathy. Of the 206 respondents who identified themselves as former researchers, nearly half cited negative experiences with their as a factor in their decision to leave academic ."

A survey finds that academic supervisors can have a huge impact on their students’ mental health.

19/04/2026

TWiV 1314: Clinical update with Dr. Daniel Griffin 🩺 Dr. Griffin and Vincent Racaniello are dismayed but not surprised by poll results suggesting most Americans doubt vaccine safety, that the head of the CDC and NIH delayed release of a report on the safety of the COVID-19 vaccine, how Nature works to spread disease without the help of the lab, and the about face of the Trump administration to nominate a pro-vaccine candidate for CDC director. Then Dr. Griffin deep dives into the measles outbreak, how the influenza vaccine may attenuate stroke and acute cardiac disease following virus infection, how to access and pay for Paxlovid, and contacting your federal government representative to stop the assault on science and biomedical research. 📺 bit.ly/4cSoRkU

15/04/2026

Now out: "When psychologizing causes harm", a joint statement by patients, clinicians and researchers 👇👇

We read with attention the article by Ranque and Cogan (1) entitled "Internal medicine at the crossroads of Long COVID diagnosis and management." W...

15/04/2026

According to a new study, RSV is associated with high rates of complications and death among older adults hospitalized with the condition, and older RSV patients may have worse health outcomes than older adults hospitalized for influenza.

Read more: https://ow.ly/Cf9E50YIpwo

15/04/2026

De novo recovery of Ghana virus, an African bat Henipavirus, reveals differential tropism and attenuated pathogenicity compared to Nipah virus

http://dlvr.it/TRzMZm

15/04/2026

TWiV 1312: Clinical update with Dr. Daniel Griffin 🩺 Dr. Griffin and Vincent Racaniello are aghast at the CDC’s decision to no longer test for rabies and mpox and the revised charter for its advisory committee on immunization practices. Then Dr. Griffin deep dives into the measles outbreak, PEMGARDA authorized use for certain immunocompromised individuals, how to access and pay for Paxlovid, if the nasal microbiome modulates COVID-19 disease severity, and contacting your federal government representative to stop the assault on science and biomedical research. 📺 bit.ly/4spVJpK

15/04/2026

Dr. Jean Paul Carrera (GVN; Gorgas Memorial Institute for Health Studies) presented “Emergence And Spread Of Oropouche Virus In The Darién Gap, Panama” during the Arboviral Threats session at on March 5, 2026.

He examined the emergence and spread of Oropouche virus in the Darién Gap, highlighting the role of field-based surveillance in understanding and responding to emerging arboviral threats.

Read the release: https://gvn.org/global-virus-network-annual-meeting-advances-a-science-driven-agenda-for-pandemic-preparedness/

13/04/2026

Dr. Eduardo Gotuzzo (GVN Center of Excellence Director; Universidad Peruana Cayetano Heredia), spoke during the Oncogenesis and Retroviruses panel at the on March 4, 2026.

He highlighted key risk factors for HTLV-associated malignancies, including early-life infection, high proviral load, severe co-infections, and family history.

Gotuzzo emphasized the importance of identifying which infected individuals are most likely to progress to malignancy so clinicians can better monitor disease risk and improve long-term outcomes.

Read the release: https://ow.ly/Yc0m50YGux6